Health Care & Life Sciences » Pharmaceuticals | Targeted Medical Pharma Inc.

Targeted Medical Pharma Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2011
2012
2013
2014
2015
Net Income before Extraordinaries
4,177.10
9,586.20
9,337.60
3,895.00
3,067.20
Depreciation, Depletion & Amortization
457.80
435.80
411.90
401.90
230.70
Other Funds
602.90
-
-
-
-
Funds from Operations
4,786.10
4,534.20
2,266.20
2,417.40
2,391.60
Changes in Working Capital
2,200.50
2,160.80
219.60
3,197.70
1,112.90
Net Operating Cash Flow
2,585.60
2,373.40
2,046.60
780.30
1,278.60
Capital Expenditures
512.30
294.90
121.40
-
-
Purchase/Sale of Investments
244.40
-
-
-
-
Net Investing Cash Flow
267.90
294.90
121.40
-
-
Issuance/Reduction of Debt, Net
1,602.00
2,847.50
2,083.20
1,500.40
1,349.50
Net Financing Cash Flow
2,204.90
2,847.50
2,333.20
1,260.40
1,349.50
Net Change in Cash
648.60
179.20
165.20
480.10
70.90
Free Cash Flow
2,667.90
2,488.90
2,084.60
780.30
1,278.60
Deferred Taxes & Investment Tax Credit
2,471.60
3,181.00
5,665.60
-
-
Change in Capital Stock
-
-
250.00
240.00
-

About Targeted Medical Pharma

View Profile
Address
2980 Beverly Glen Circle
Los Angeles California 90077
United States
Employees -
Website http://www.tmedpharma.com
Updated 07/08/2019
Targeted Medical Pharma, Inc. engages in the research, development, and commercialization of amino acid based medications. It operates through the following segments: Targeted Medical Pharma ("TMP"); Complete Claims Processing, Inc. ("CCPI"); and Amino Nutritionals. The TMP segment offers physician therapeutics, medical foods, and generic medicines.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.